ASCEND Clinical Data Services™
Technology enabled clinical data services to help emerging and mid-market biopharmaceutical companies succeed and scale.
Regain Control of Your Data
ASCEND Clinical Data Services addresses the unique needs of emerging and mid-market sponsored trials. Clinical teams working in a highly outsourced model, now more than ever, need increased data access, standardization, and control. The combination of the Medidata Rave Clinical Cloud for data acquisition and the elluminate Clinical Data Platform delivers modern agile data management.
Accelerate Your Clinical Trial with ASCEND and Regain Control of Your Data
Rapid, Traceable Deployment of New and Ongoing Studies
Data Acquisition Approach
ASCEND Data Services Reduce Data Chaos:
- Ownership of your Medidata RAVE platform including the Rave URL
- Development of your Global Library including eCRF & eCOA forms and instruments across the entire collection platform for maximizing program efficiency, quality and reuse
- Data access, oversight and visibility through the elluminate Clinical Data Platform with real-time analytics for all data sources, i.e. Lab, Biomarkers, Pharmacokinetics
- Technology enabled data review and statistical analysis with continuous data cleaning and statistical review and support throughout your trial
eClinical Solutions and Medidata are trusted partners with a close collaboration that spans more than 12 years.
Together, eClinical Solutions and Medidata help clients regain control over their data assets while increasing their ability to conduct comprehensive oversight and review activities across all data sources for faster decision making and time to analysis.
Interview with Senior Director of Clinical Data Management, Sarepta Therapeutics
ASCEND in Action
Today, after collaborating on 20 trials, 95% of forms and 50% of edit checks are reusable, which facilitates rapid study startup. By implementing ASCEND and Medidata solutions, Sarepta has been able to increase standardization of trial design, streamline its data collection strategy and ultimately accelerate the clinical trial process.
